Share on:

Share on LinkedIn Share on X Share on Facebook Share with email

Testimonial

"We’re proud to call I-Connect007 a trusted partner. Their innovative approach and industry insight made our podcast collaboration a success by connecting us with the right audience and delivering real results."

Julia McCaffrey - NCAB Group

Suggested Items

WWII Meteorologist Turned Material Scientist Shares Nobel Prize in Chemistry 2019

10/28/2019 | U.S. Air Force
The Air Force Office of Scientific Research congratulates John B. Goodenough, professor in the Cockrell School of Engineering at The University of Texas at Austin, for recently being awarded the Nobel Prize in Chemistry 2019. Goodenough is the eldest recipient of a Nobel Prize at age 97.

Partnership to Develop an All-Perovskite Solar Cell

09/27/2018 | Oxford PV
Oxford PV, The Perovskite Company, the leader in the field of perovskite solar cells, announced a five year research project with the University of Oxford to develop a thin-film multi-junction perovskite solar cell, with a target 37% efficiency and long term stability.

Oxford PV Leads Consortium to Prepare Perovskite Solar Cells for High Volume Manufacturing

08/24/2018 | Oxford PV
The project has received Euro 2.8 million from the German Ministry of Economic Affairs and Energy as part of its wider investment programme into renewable energy development.

Funding for Preparing Perovskite Solar Cells for High Volume Manufacturing

08/24/2018 | HZB
HZB participates in a new consortium for Perovskite solar technology that is led by Oxford PV Germany GmbH. The consortium is funded by the German Ministry of Economics and Energy with 2.8 Million Euros and aims to further demonstrate the manufacturability of perovskite-silicon tandem solar cells.

First Robotical System for Eye Surgery of Spin-off Preceyes Goes to Oxford

03/04/2016 | TU Eindhoven
Preceyes, a spin-off of TU/e, and Nightstar (UK) have entered into a collaboration for the development of a high-precision drug delivery technology in the eye. Nightstar will use the Preceyes robotic device to further refine the delivery of gene therapy to the subretinal space for a range of inherited retinal diseases. In the course of the collaboration, Nightstar will purchase the PRECEYES Surgical System for use in human gene therapy trials.
Copyright © I-Connect007 | IPC Publishing Group Inc. All rights reserved. Log in